[ Cancer Research Institute - CRI Irvington Postdoctoral Fellowship Program | Fellowship Funding ]
Event details
| Date | 01.04.2021 |
| Category | Call for proposal |
Aim: The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists at leading universities and research centers around the world. The Institute seeks hypothesis-driven, mechanistic studies in both immunology and tumor immunology. The applicant and sponsor should make every effort to demonstrate the potential of the proposed studies to directly impact our understanding of the immune system’s role in cancer.
Additional opportunities: This year, in collaboration with the Fibrolamellar Cancer Foundation, CRI has secured limited funding for additional postdoctoral fellowships for projects focused on understanding the immunological response to fibrolamellar carcinoma and accelerating the development of effective immunotherapy treatments for this rare, aggressive liver cancer. Applicants should submit to the general CRI Irvington Postdoctoral Fellowship Program and any application in this area will be considered eligible for this special funding opportunity, which comes in addition to our standard call for applications.
CRI Irvington Postdoctoral Fellowship: General and Fibrolamellar Carcinoma-funded Programs
Duration: 3 years
Funding: Year 1 - $55,000 stipend
Year 2 - $57,000 stipend
Year 3 - $59,000 stipend
Each year - $1,500 allowance for research or travel
Eligibility: Applicant must hold a doctorate degree by the date of award activation, but have no more than 5 years postdoctoral experience. Must be sponsored by a senior researcher with a formal appointment at the host institution.
How to Apply: Proposal materials, including an application form, background statement, CV, research proposal, and supporting letters, must be uploaded via the online portal. Note that the proposal must be approved and signed by the host institution’s administrative officials.
Application Deadline: 01 April 2021 (5:00 pm EST)
Further information
Additional opportunities: This year, in collaboration with the Fibrolamellar Cancer Foundation, CRI has secured limited funding for additional postdoctoral fellowships for projects focused on understanding the immunological response to fibrolamellar carcinoma and accelerating the development of effective immunotherapy treatments for this rare, aggressive liver cancer. Applicants should submit to the general CRI Irvington Postdoctoral Fellowship Program and any application in this area will be considered eligible for this special funding opportunity, which comes in addition to our standard call for applications.
CRI Irvington Postdoctoral Fellowship: General and Fibrolamellar Carcinoma-funded Programs
Duration: 3 years
Funding: Year 1 - $55,000 stipend
Year 2 - $57,000 stipend
Year 3 - $59,000 stipend
Each year - $1,500 allowance for research or travel
Eligibility: Applicant must hold a doctorate degree by the date of award activation, but have no more than 5 years postdoctoral experience. Must be sponsored by a senior researcher with a formal appointment at the host institution.
How to Apply: Proposal materials, including an application form, background statement, CV, research proposal, and supporting letters, must be uploaded via the online portal. Note that the proposal must be approved and signed by the host institution’s administrative officials.
Application Deadline: 01 April 2021 (5:00 pm EST)
Further information
- More information about the program is available here.
- The application portal can be found here.
- For any other questions, please contact the Research Office.
Practical information
- General public
- Free